Bausch Health Companies (NYSE:BHC) Issues Earnings Results

Bausch Health Companies (NYSE:BHC) issued its quarterly earnings data on Wednesday. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.44), Zacks reports. The company had revenue of $2.56 billion during the quarter, compared to the consensus estimate of $2.51 billion. Bausch Health Companies had a negative return on equity of 650.39% and a negative net margin of 0.48%. Bausch Health Companies updated its FY 2025 guidance to EPS.

Bausch Health Companies Trading Up 10.2 %

Shares of NYSE:BHC opened at $7.18 on Friday. The stock has a fifty day simple moving average of $7.36 and a two-hundred day simple moving average of $7.46. Bausch Health Companies has a 12-month low of $3.96 and a 12-month high of $11.46.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on BHC shares. Royal Bank of Canada decreased their price target on shares of Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a research note on Thursday, January 30th. Jefferies Financial Group reissued a “hold” rating and issued a $8.00 target price (down previously from $12.00) on shares of Bausch Health Companies in a research report on Thursday, February 6th. Finally, StockNews.com upgraded Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Friday, October 25th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Bausch Health Companies has an average rating of “Hold” and an average target price of $7.42.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.